| RS372299853 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS372301151 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-pancytopenia syndrome, Ataxia-pancytopenia syndrome |
| RS372301689 |
ARHGAP31
|
Health Risk |
Conflicting classifications of pathogenicity |
ARHGAP31-related disorder, ARHGAP31-related disorder |
| RS372301724 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS372302139 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia |
| RS372302484 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS372302682 |
PPA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372303141 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS372303284 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS372303620 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS372304158 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS372304384 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial spontaneous pneumothorax, Birt-Hogg-Dube syndrome |
| RS372305218 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1 |
| RS372305287 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS372306607 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
RHOBTB2-related disorder, Developmental and epileptic encephalopathy |
| RS372306844 |
SLC7A9
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystinuria, Cystinuria |
| RS372307320 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS372307932 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS372308762 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372308925 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, CREBBP-related disorder |
| RS372309164 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS372309415 |
LITAF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease type 1C |
| RS372311299 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Chromosome 2p16.3 deletion syndrome |
| RS372311430 |
CIT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372312182 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS372312805 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS372313516 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS372313619 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS372314209 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS372315353 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Supravalvar aortic stenosis, Cutis laxa |
| RS372316277 |
ARSL
|
Health Risk |
Likely pathogenic |
Chondrodysplasia punctata, brachytelephalangic |
| RS372316501 |
TONSL
|
Health Risk |
Conflicting classifications of pathogenicity |
TONSL-related disorder, Inborn genetic diseases |
| RS372316981 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS372317366 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myoclonic epilepsy, Developmental and epileptic encephalopathy |
| RS372318280 |
FOXRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372318389 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectrodactyly, ectodermal dysplasia |
| RS372318754 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS372318763 |
CSF3R
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Inborn genetic diseases |
| RS372318863 |
EXOSC9
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia, type 1D |
| RS372319066 |
TECPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia |
| RS372319281 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS372319442 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS372319750 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372320153 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS372320172 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS372320290 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS372320539 |
COL9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart disease, Inborn genetic diseases |
| RS372320901 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS372321135 |
CYP1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glaucoma, Inborn genetic diseases |
| RS372321167 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372321643 |
MTTP
|
Health Risk |
Pathogenic/Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS372321790 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS372322137 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary xanthinuria type 1, Xanthinuria type II |
| RS372323929 |
PCARE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372324595 |
OTOF
|
Health Risk |
Pathogenic |
— |
| RS372325290 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS372326047 |
UGT1A1
|
Health Risk |
Pathogenic |
— |
| RS372326315 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, ABCA12-related disorder |
| RS372327659 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Melanoma |
| RS372328307 |
KCNJ5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperaldosteronism type III, Familial hyperaldosteronism type III |
| RS372328602 |
RANBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372328960 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS372329290 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS372329498 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS372329880 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS372331472 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS372331627 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Arrhythmogenic right ventricular cardiomyopathy |
| RS372331667 |
TNFRSF13C
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS372332465 |
CANT1
|
Health Risk |
Pathogenic |
— |
| RS372333024 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate E, Focal segmental glomerulosclerosis 5 |
| RS372333417 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
TJP2-related disorder, TJP2-related disorder |
| RS372337472 |
KIF22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372337556 |
F8
|
Health Risk |
Pathogenic |
— |
| RS372337739 |
TSFM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS372337877 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Magenis syndrome, RAI1-related disorder |
| RS372337934 |
ZFHX3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372338345 |
KIZ
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372338418 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS372338710 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS372338837 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS372338933 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS372340726 |
GLIS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal diabetes mellitus with congenital hypothyroidism, GLIS3-related disorder |
| RS372340900 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS372341254 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS372341303 |
GLI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS372341590 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS372341850 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS372342635 |
PNPLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutral lipid storage myopathy, PNPLA2-related disorder |
| RS372343882 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS372344160 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, FG syndrome |
| RS372344870 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal dominant nonsyndromic hearing loss 11 |
| RS372345029 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IB |
| RS372345940 |
C6
|
Health Risk |
Pathogenic |
Complement component 6 deficiency, Complement component 6 deficiency |
| RS372346014 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hydrocephalus |
| RS372346318 |
TRIM31
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372346466 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS372346866 |
PDE6A
|
Health Risk |
Likely pathogenic |
— |
| RS372346898 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS372347027 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS372347288 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |